SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-21-032747
Filing Date
2021-08-12
Accepted
2021-08-12 16:15:00
Documents
1
Period of Report
2021-01-11

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 6638
  Complete submission text file 0000899243-21-032747.txt   8087
Mailing Address C/O CREDIT SUISSE 1ST BOSTON PRV EQY 11 MADISON AVENUE NEW YORK NY 10010
Business Address
HUNT RONALD (Reporting) CIK: 0001247851 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38800 | Film No.: 211167739

Mailing Address 131 OYSTER POINT BOULEVARD SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 131 OYSTER POINT BOULEVARD SUITE 300 SOUTH SAN FRANCISCO CA 94080 650-443-7400
Harpoon Therapeutics, Inc. (Issuer) CIK: 0001708493 (see all company filings)

IRS No.: 473458693 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)